Nello Mainolfi

Company: Kymera Therapeutics

Job title: Founder, President & Chief Executive Officer

Seminars:

Targeted Protein Degradation Beyond Oncology 8:30 am

Advancing understanding and impact of TPD beyond existing E3 ligases What is needed to build programs beyond oncology IRAK4 degrader programs in immunologyRead more

day: Day Two